Srinivas Venkanna Samudrala
About Srinivas Venkanna Samudrala
Data last updated:
Srinivas Venkanna Samudrala has 10 years in corporate governance. Holds Director role. Currently with 1 company, including Krisnim Consulting Solutions And Services India Private Limited. Formerly with 2 companies, such as Cmix India Private Limited and Etico Lifesciences Private Limited. Engaged in General Business. Contributes to corporate operations.
Current companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
 Krisnim Consulting Solutions And Services India Private Limited U72900TG2016PTC113445 | Director | 16 Dec 2016 | 2016 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
| Cmix India Private Limited U36109TG2016PTC109565 | Director | 20 Jun 2016 | 2016 | Active |
 Etico Lifesciences Private Limited U24100TG2016PTC111290 | Additional Director | 07 Aug 2017 | 2016 | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Srinivas Venkanna Samudrala
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Srinivas Venkanna Samudrala
Srinivas Venkanna Samudrala has 10 years in corporate governance. Holds Director role. Currently with 1 company, including Krisnim Consulting Solutions And Services India Private Limited. Formerly with 2 companies, such as Cmix India Private Limited and Etico Lifesciences Private Limited. Engaged in General Business. Contributes to corporate operations.
Srinivas Venkanna Samudrala is associated with 1 company as Director.
Srinivas Venkanna Samudrala has expertise in General Business.
Srinivas Venkanna Samudrala has 10 years in corporate governance.